M.A. Vázquez

1.0k total citations
45 papers, 452 citations indexed

About

M.A. Vázquez is a scholar working on Surgery, Molecular Biology and Orthopedics and Sports Medicine. According to data from OpenAlex, M.A. Vázquez has authored 45 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 13 papers in Molecular Biology and 12 papers in Orthopedics and Sports Medicine. Recurrent topics in M.A. Vázquez's work include Bone health and osteoporosis research (11 papers), Bone Metabolism and Diseases (9 papers) and Bone health and treatments (6 papers). M.A. Vázquez is often cited by papers focused on Bone health and osteoporosis research (11 papers), Bone Metabolism and Diseases (9 papers) and Bone health and treatments (6 papers). M.A. Vázquez collaborates with scholars based in Spain, United States and Chile. M.A. Vázquez's co-authors include Mercè Giner, Ramón Pérez‐Cano, María-José Montoya-García, María Teresa Muñoz-Quezada, Jesús Argente, Federico Hawkins, Julio Pascual, Esteban Jódar, Yadir Torres and Javier P. Gisbert and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Journal of Bone and Mineral Research.

In The Last Decade

M.A. Vázquez

42 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.A. Vázquez Spain 14 145 145 140 86 78 45 452
A. Prewett United States 9 134 0.9× 108 0.7× 106 0.8× 46 0.5× 70 0.9× 10 484
Daniel Clark United States 8 133 0.9× 54 0.4× 123 0.9× 26 0.3× 38 0.5× 12 531
Enrico Nastro Siniscalchi Italy 16 45 0.3× 120 0.8× 170 1.2× 21 0.2× 183 2.3× 43 685
João Francisco Marques Neto Brazil 11 41 0.3× 132 0.9× 65 0.5× 22 0.3× 47 0.6× 25 358
Henrik Eckardt Switzerland 15 100 0.7× 70 0.5× 540 3.9× 67 0.8× 50 0.6× 31 802
P. Vescovi Italy 15 139 1.0× 187 1.3× 71 0.5× 47 0.5× 294 3.8× 43 883
Joseph C. Giaconi United States 11 54 0.4× 174 1.2× 228 1.6× 23 0.3× 39 0.5× 18 481
D. Douglas Miley United States 9 85 0.6× 45 0.3× 85 0.6× 18 0.2× 100 1.3× 17 538
S. Tsitsilonis Germany 13 53 0.4× 142 1.0× 320 2.3× 16 0.2× 27 0.3× 39 533
Jean-Charles Aurégan France 16 46 0.3× 226 1.6× 482 3.4× 68 0.8× 32 0.4× 59 813

Countries citing papers authored by M.A. Vázquez

Since Specialization
Citations

This map shows the geographic impact of M.A. Vázquez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Vázquez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Vázquez more than expected).

Fields of papers citing papers by M.A. Vázquez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.A. Vázquez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Vázquez. The network helps show where M.A. Vázquez may publish in the future.

Co-authorship network of co-authors of M.A. Vázquez

This figure shows the co-authorship network connecting the top 25 collaborators of M.A. Vázquez. A scholar is included among the top collaborators of M.A. Vázquez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.A. Vázquez. M.A. Vázquez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giner, Mercè, et al.. (2022). Circulating Osteogenic Progenitor Cells Enhanced with Teriparatide or Denosumab Treatment. Journal of Clinical Medicine. 11(16). 4749–4749. 1 indexed citations
2.
Giner, Mercè, E. Chicardi, Alzenira F. Costa, et al.. (2021). Biocompatibility and Cellular Behavior of TiNbTa Alloy with Adapted Rigidity for the Replacement of Bone Tissue. Metals. 11(1). 130–130. 12 indexed citations
3.
4.
Montoya-García, María-José, et al.. (2021). Fragility Fractures and Imminent Fracture Risk in the Spanish Population: A Retrospective Observational Cohort Study. Journal of Clinical Medicine. 10(5). 1082–1082. 8 indexed citations
5.
Giner, Mercè, M.A. Vázquez, Patricia Altea‐Manzano, et al.. (2021). Microstructural and Strength Changes in Trabecular Bone in Elderly Patients with Type 2 Diabetes Mellitus. Diagnostics. 11(3). 577–577. 10 indexed citations
6.
Civantos, Ana, Mercè Giner, Paloma Trueba, et al.. (2020). In Vitro Bone Cell Behavior on Porous Titanium Samples: Influence of Porosity by Loose Sintering and Space Holder Techniques. Metals. 10(5). 696–696. 27 indexed citations
7.
Marini, M., et al.. (2020). Endovascular Treatment of Spleno-Mesenteric-Portal Vein Thrombosis During Orthotopic Liver Transplant: 20 Years Later. Transplantation Proceedings. 52(5). 1459–1463. 2 indexed citations
8.
Vázquez, M.A., et al.. (2020). Incidence, morbidity and mortality of hip fractures over a period of 20 years in a health area of Southern Spain. BMJ Open. 10(9). e037101–e037101. 14 indexed citations
9.
Castro-Laria, Luisa, Angel Caunedo-Álvarez, María-José Montoya-García, et al.. (2018). Does the Antitumor Necrosis Factor-α Therapy Decrease the Vertebral Fractures Occurrence in Inflammatory Bowel Disease?. Journal of Clinical Densitometry. 22(2). 195–202. 14 indexed citations
10.
Vázquez, M.A., et al.. (2017). Influencia de la vitamina D sobre la microestructura y propiedades biomecánicas de pacientes con fractura de cadera. SHILAP Revista de lepidopterología. 9(4). 121–129. 2 indexed citations
11.
12.
Giner, Mercè, et al.. (2012). Study of Bone Mass in Young Daughters of Women With Fracture of the Distal End of the Radius. Journal of Clinical Densitometry. 16(1). 87–91. 2 indexed citations
13.
Montoya-García, María-José, et al.. (2011). ¿Se fracturan la cadera los hombres y las mujeres ante los mismos factores de riesgo?. Revista Clínica Española. 211(10). 495–503. 4 indexed citations
14.
Giner, Mercè, et al.. (2010). Alendronate and raloxifene affect the osteoprotegerin/RANKL system in human osteoblast primary cultures from patients with osteoporosis and osteoarthritis. European Journal of Pharmacology. 650(2-3). 682–687. 22 indexed citations
15.
Giner, Mercè, María-José Montoya-García, M.A. Vázquez, et al.. (2008). Modifying RANKL/OPG mRNA Expression in Differentiating and Growing Human Primary Osteoblasts. Hormone and Metabolic Research. 40(12). 869–874. 11 indexed citations
16.
Vázquez, M.A., et al.. (2007). Anthropometric, Bone Age, and Bone Mineral Density Changes after a Family-Based Treatment for Obese Children. Calcified Tissue International. 81(4). 279–284. 4 indexed citations
17.
Gisbert, Javier P., Julio Ducóns, Fernando Gomollón, et al.. (2003). Validación de la prueba del aliento con 13C-urea para el diagnóstico inicial de la infección por Helicobacter pylori y la confirmación de su erradicación tras el tratamiento. Revista Española de Enfermedades Digestivas. 95(2). 115–120. 6 indexed citations
18.
Gisbert, Javier P., et al.. (2002). Estudio de la validez de la serología «rápida» para el diagnóstico de la infección por Helicobacter pylori. Atención Primaria. 30(8). 501–506. 3 indexed citations
19.
Pascual, Julio, Jesús Argente, María Teresa Muñoz-Quezada, et al.. (1998). Bone Mineral Density in Children and Adolescents with Diabetes Mellitus Type 1 of Recent Onset. Calcified Tissue International. 62(1). 31–35. 56 indexed citations
20.
Cano, R. Pérez, et al.. (1989). ADFR therapy in the prevention of bone loss after menopause. Clinical Rheumatology. 8(S2). 56–60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Prewett Breakdown of academic impact, for papers by Daniel Clark Breakdown of academic impact, for papers by Enrico Nastro Siniscalchi Breakdown of academic impact, for papers by João Francisco Marques Neto Breakdown of academic impact, for papers by Henrik Eckardt Breakdown of academic impact, for papers by P. Vescovi Breakdown of academic impact, for papers by Joseph C. Giaconi Breakdown of academic impact, for papers by D. Douglas Miley Breakdown of academic impact, for papers by S. Tsitsilonis Breakdown of academic impact, for papers by Jean-Charles Aurégan
Rankless by CCL
2026